Treatment with an oral direct thrombin inhibitor decreases platelet activity but increases markers of inflammation in patients with myocardial infarction. [electronic resource]
Producer: 20111003Description: 215-23 p. digitalISSN:- 1365-2796
- Administration, Oral
- Aged
- Aged, 80 and over
- Antithrombins -- administration & dosage
- Aspirin -- administration & dosage
- Azetidines -- administration & dosage
- Benzylamines -- administration & dosage
- Biomarkers -- blood
- Blood Platelets -- drug effects
- C-Reactive Protein -- metabolism
- Comorbidity
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Humans
- Inflammation -- blood
- Interleukin-10 -- blood
- Interleukin-18 -- blood
- Male
- Middle Aged
- Myocardial Infarction -- blood
- P-Selectin -- blood
- Platelet Activation -- drug effects
- Risk Factors
- Thromboplastin -- metabolism
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.